In 2023, tuberculosis treatment coverage in France stood at 85%. The forecast from 2024 to 2028 shows a steady slight increase, with coverage expect to rise to 86% in 2024 and 87% from 2025 onwards.
While year-on-year growth is minimal, indicating a stabilization of treatment coverage, the compound annual growth rate (CAGR) over this period remains consistent, suggesting ongoing efforts to improve treatment accessibility and adherence in France.
Future trends to watch for include:
- Technological advancements and innovations in tuberculosis diagnostics and treatment that could significantly impact coverage rates.
- Policy changes or healthcare reforms aiming to bolster public health infrastructure which might enhance tuberculosis control efforts.
